ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0449

Higher Disease Acuity at Presentation and Increased Lower Respiratory Involvement in Hispanic and Black Patients with ANCA-Associated Vasculitis

Mark Riley1, Wenlu Xiong1 and Najia Shakoor2, 1Rush University Medical Center, Chicago, IL, 2Rush University, Hinsdale, IL

Meeting: ACR Convergence 2022

Keywords: ANCA associated vasculitis, race/ethnicity

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 12, 2022

Title: Vasculitis – ANCA-Associated Poster I: Epidemiology, Outcomes, and Classification

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: ANCA-associated vasculitis (AAV) is a systemic small-vessel vasculitis comprising granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), eosinophilic granulomatosis with polyangiitis (EGPA), and renal-limited vasculitis (RLV). Currently, data is limited and conflicting regarding racial and ethnic differences in disease severity and outcomes. Previous studies reported Hispanic patients with AAV presented with more severe disease and had higher damage indices compared to Caucasian patients1, while others showed no difference in the outcomes between African American and Caucasian patients with AAV2. The purpose of this study was to investigate for racial and ethnic differences in disease severity in patients with AAV at a tertiary care center.

Methods: This retrospective chart review was conducted using the electronic medical record at Rush. Inclusion criteria were: age > 18; diagnosis of AAV, GPA, MPA, EGPA or RLV; and evaluation by a rheumatologist between 2010 and 2020. Patients with drug-induced AAV, any other form of vasculitis, or concurrent chronic infection were excluded. Demographics, diagnosis, organ involvement, laboratory data, and hospitalization data were collected. Birmingham Vasculitis Activity Scores (BVAS)3 were calculated at presentation, 6 months, and 12 months after diagnosis. Data was analyzed using independent samples t-tests and Chi-square in SPSS. Hispanic and Black patients were grouped together and compared to the non-Hispanic non-Black patients.

Results: Of the 56 patients who met inclusion criteria, 38 were non-Hispanic non-Black (37 Caucasian patients and 1 Asian patient with 12 males and 16 females), and 18 were Hispanic or Black (8 Black patients and 10 Hispanic patients with 4 males and 14 females). Lower respiratory involvement (p = 0.041) and hospital admission at presentation (p = 0.027) were more common in Hispanic or Black patients, while neurologic involvement was more common in the non-Hispanic non-Black group (p = 0.035) as seen in Table 1. As seen in Table 2, mean time to diagnosis was shorter in the Hispanic or Black cohort (3.2 months) compared to the non-Hispanic non-Black cohort (10.5 months) although the difference did not reach statistical significance (p = 0.130). Mean peak C-reactive protein (CRP) level was higher among Hispanic or Black patients (89.9 mg/L) compared to the non-Hispanic non-Black group (40.3 mg/L) although the difference did not reach statistical significance (p = 0.69). BVAS values at presentation, 6 months, and 12 months were similar between the two groups.

Conclusion: Hispanic and Black patients with AAV had a significantly higher rate of hospitalization at presentation and significantly more lower respiratory involvement. These findings suggest Hispanic and Black patients with AAV present with higher disease acuity at presentation, potentially due to more severe lung involvement such as diffuse alveolar hemorrhage and/or acute respiratory failure, compared to non-Hispanic non-Black patients with AAV. The study also showed higher peak CRP values and shorter time to diagnosis although these findings were not statistically significant. Further study is needed to confirm these findings with a larger sample size.

Supporting image 1

*Differences were statistically significant with p-value < 0.05

Supporting image 2


Disclosures: M. Riley, None; W. Xiong, None; N. Shakoor, DJO.

To cite this abstract in AMA style:

Riley M, Xiong W, Shakoor N. Higher Disease Acuity at Presentation and Increased Lower Respiratory Involvement in Hispanic and Black Patients with ANCA-Associated Vasculitis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/higher-disease-acuity-at-presentation-and-increased-lower-respiratory-involvement-in-hispanic-and-black-patients-with-anca-associated-vasculitis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/higher-disease-acuity-at-presentation-and-increased-lower-respiratory-involvement-in-hispanic-and-black-patients-with-anca-associated-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology